Is HIMS Worth Buying in 2026?

Hims & Hers Health, Inc.

STOCK SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE Updated 2026-08-23

Here’s whether Hims & Hers Health, Inc. (HIMS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.87% over 10 days); RSI 58 — healthy momentum range; 3-month momentum positive (+42.2%). Concerns: weak 1-year return of -23.2%. Currently 48.3% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

HIMS is in a confirmed uptrend, trading above both its 50-day ($32.03) and 200-day ($28.89) moving averages. An RSI of 58.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -23.2% compares to +20.5% for SPY (trailed the market by 43.6%). The current 48.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,684 today
vs. S&P 500 (SPY) — same period trailed market by 43.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($28.89)
Above 50-day MA ($32.03)
RSI(14) neutral zone (30–70) — currently 58.4
Positive return (-23.2%)
!Within 10% of period high (−48.3%)
Period Range $33.78
$13.74 $65.30
RSI (14) 58.4
0 · OversoldOverbought · 100

Key Metrics

Price$33.78
Period Return-23.2%
Period High$65.30
Period Low$13.74
Drawdown−48.3%
MA-50$32.03
MA-200$28.89
RSI (14)58.4
Avg Volume (30d)14.5M
vs. SPYtrailed by 43.6%
Return Rank#760 of 999

Trade HIMS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers